Skip to main content

Reptilase Time

CPT

85635

  • Share
  • Print
  • Updated on 06/29/2026

Test Details

Methodology

The reptilase time measures the rate of fibrin clot formation after the addition of reptilase, a proteolytic enzyme derived from the venom of Bothrops atrox, to citrated plasma.

Result Turnaround Time

2 - 3 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Information

Related Documents

For more information, please view the literature below.

Use

This test is used for diagnosis of fibrinogen deficiency, both congenital and acquired, as well as screen for dysfibrinogenemia.6 Normal values for reptilase time when thrombin time is prolonged suggests the presence of heparin or a direct thrombin inhibitor.

Limitations

This test is a qualitative assay of fibrinogen function and does not always indicate a specific disorder, thus additional testing may be required for clarification of prolongation in test results.

Custom Additional Information

Reptilase is a thrombin-like enzyme. Unlike thrombin, which cleaves fibrinogen to produce fibrinopeptides A and B, reptilase cleaves the fibrinogen molecule to release only fibrinopeptide A.6,7 Reptilase time may be more sensitive than a thrombin time to the presence of a dysfibrinogenemia. The reptilase clotting time may be used in place of, or in conjunction with, the thrombin time to measure fibrin formation. Both reptilase time and thrombin time will be extended when functional fibrinogen levels are <100 mg/dL.6,7 This can occur due to congenital conditions, including afibrinogenemia (complete lack of fibrinogen), hypofibrinogenemia, and in dysfibrinogenemia, a condition characterized by the presence of dysfunctional fibrinogen. 

Acquired conditions that can lead to diminished fibrinogen levels and extended reptilase times include liver disease, renal disease, disseminated intravascular coagulation (DIC), amyloidosis, malignancy and thrombolytic therapy.6 Paraproteins and fibrin degradation products, especially fragments D and E, interfere in fibrin polymerization, thus prolonging both the thrombin time and reptilase time. 

Bovine thrombin inhibitors (antibovine thrombin antibody) may develop in patients previously treated with “fibrin glue” during surgical procedures (most fibrin glue products contain bovine thrombin). This acquired inhibitor prolongs the (bovine-derived reagent) thrombin time, but does not prolong the reptilase time. A thrombin time using human-derived thrombin reagent will not be prolonged in the presence of a bovine thrombin inhibitor. 

Unlike thrombin, reptilase is not affected by the presence of heparin, heparinoids or hirudin and may be a useful tool in evaluating test plasma for their presence.6 A prolonged thrombin time in a patient with a normal reptilase time suggest heparin therapy or contamination.

Specimen Requirements

Specimen

Plasma, frozen

Volume

1 mL

Container

Blue-top (sodium citrate) tube

Collection Instructions

Citrated plasma samples should be collected by double centrifugation. Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.1 Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio.2,3 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples, except when using a winged blood collection device (i.e., "butterfly"), in which case a discard tube should be used.4,5 When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternate anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Centrifuge for 10 minutes and carefully remove 2/3 of the plasma using a plastic transfer pipette, being careful not to disturb the cells. Deliver to a plastic transport tube, cap, and recentrifuge for 10 minutes. Use a second plastic pipette to remove the plasma, staying clear of the platelets at the bottom of the tube. Transfer the plasma into a Labcorp PP transpak frozen purple tube with screw cap (Labcorp No. 49482). Freeze immediately and maintain frozen until tested.

Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.

Stability Requirements

TemperaturePeriod
Frozen28 days
Freeze/thaw cyclesStable x3

Reference Range

0.0–20.0 sec8

Storage Instructions

Freeze.

Patient Preparation

Ideally, the patient should not be on anticoagulant therapy. Avoid warfarin (Coumadin®) therapy for two weeks prior to the test and heparin, direct Xa and thrombin inhibitor therapies for about three days prior to testing. Do not draw from an arm with a heparin lock or heparinized catheter.

Causes for Rejection

Severe hemolysis; improper labeling; clotted specimen; specimen diluted with IV fluids; samples thawed in transit; improper sample type; sample out of stability

References

Mackie I, Casini A, Pieters M, Pruthi R, Reilly-Stitt C, Suzuki A. International council for standardisation in haematology recommendations of fibrinogen assays, thrombin clotting time and related test in the investigation of bleeding disorders. Int J Lab Hematol. 2024;46(1):20-32. PubMed 37984807

Thelwell C, Rigsby P, Locke M, Bevan S, Longstaff C. An international collaborative study to calibrate the WHO 2nd International Standard for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin (15/140): communication from the SSC of the ISTH. J Thromb Haemost. 2018;16(5):1003-1006. PubMed 29607604

Footnotes

1. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol. 1997 Jan;107(1):105-110. 8980376
2. Reneke J, Etzell J, Leslie S, Ng VL, Gottfried EL. Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol. 1998 Jun;109(6):754-757. 9620035
3. Clinical Laboratory Standards Institute (CLSI). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays. 6th ed. CLSI guideline H21. Clinical and Laboratory Standards Institute; 2024.
4. Gottfried EL, Adachi MM. Prothrombin time and activated partial thromboplastin time can be performed on the first tube. Am J Clin Pathol. 1997 Jun;107(6):681-683. 9169665
5. McGlasson DL, More L, Best HA, Norris WL, Doe RH, Ray H. Drawing specimens for coagulation testing: Is a second tube necessary? Clin Lab Sci. 1999 May-Jun;12(3):137-139. 10539100
6. Karapetian H. Reptilase time (RT). Methods Mol Biol. 2013;992:273-277. PubMed 23546720 
7. Van Cott EM, Laposata M. Coagulation. In: Jacobs DS, Oxley DK, DeMott WR, eds. Laboratory Test Handbook With Key Word Index. 5th ed. Hudson, Ohio: Lexi-Comp Inc; 2001: 327-358.
8. STA® - Reptilase® Instructions For Use (IFU) [package insert]. March 2018.

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
117180 Reptilase Time 6683-7 117181 Reptilase Time sec 6683-7
Order Code117180
Order Code NameReptilase Time
Order Loinc6683-7
Result Code117181
Result Code NameReptilase Time
UofMsec
Result LOINC6683-7